Urinary Leukotriene E ₄ Enables Rule‐In Diagnosis of NSAID ‐Exacerbated Respiratory Disease

The data that support the findings of this study are available from the corresponding author upon reasonable request. Figure S1: Study flow diagram. N-ERD, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; NT-CRSwNP, NSAID-tolerant chronic rhinosinusitis with nasal polyps. Table S1: Baseline demographic characteristics of the discovery and validation cohorts. Table S2: Diagnostic performance of urinary LTE4 for identification of N-ERD in the validation cohort at two cutoff values. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.